0.7637
price down icon7.80%   -0.0647
 
loading
Omega Therapeutics Inc stock is traded at $0.7637, with a volume of 465.57K. It is down -7.80% in the last 24 hours and down -27.95% over the past month. Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
See More
Previous Close:
$0.8284
Open:
$0.899
24h Volume:
465.57K
Relative Volume:
1.79
Market Cap:
$45.69M
Revenue:
$3.10M
Net Income/Loss:
$-97.43M
P/E Ratio:
-0.344
EPS:
-2.22
Net Cash Flow:
$-94.38M
1W Performance:
-29.93%
1M Performance:
-27.95%
6M Performance:
-68.31%
1Y Performance:
-64.31%
1-Day Range:
Value
$0.75
$0.9299
1-Week Range:
Value
$0.75
$1.17
52-Week Range:
Value
$0.75
$6.30

Omega Therapeutics Inc Stock (OMGA) Company Profile

Name
Name
Omega Therapeutics Inc
Name
Phone
(617) 949-4360
Name
Address
140 FIRST STREET, SUITE 501, CAMBRIDGE
Name
Employee
94
Name
Twitter
Name
Next Earnings Date
2024-06-20
Name
Latest SEC Filings
Name
OMGA's Discussions on Twitter

Compare OMGA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
OMGA 0.7638 45.69M 3.10M -97.43M -94.38M -2.22
VRTX 467.37 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.78 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 564.61 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.58 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.54 24.08B 3.30B -501.07M 1.03B 11.54

Omega Therapeutics Inc Stock (OMGA) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-08-22 Initiated H.C. Wainwright Buy
Sep-23-22 Initiated Chardan Capital Markets Buy

Omega Therapeutics Inc Stock (OMGA) Latest News

pulisher
Nov 17, 2024

Omega Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

Shares of Flagship-founded biotech fall as CEO departs - The Business Journals

Nov 15, 2024
pulisher
Nov 15, 2024

Omega Therapeutics (NASDAQ:OMGA) Downgraded to Market Perform Rating by Raymond James - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Piper Sandler Issues Pessimistic Forecast for Omega Therapeutics (NASDAQ:OMGA) Stock Price - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Omega Therapeutics Inc (OMGA) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics Names Kaan Certel as CEO - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics Announces Successful Completion of Phase - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Omega Therapeutics, Inc. Announces Chief Executive Officer Changes - Marketscreener.com

Nov 14, 2024
pulisher
Nov 13, 2024

Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - Financial Times

Nov 13, 2024
pulisher
Nov 08, 2024

Omega Therapeutics (NASDAQ:OMGA) Stock Price Down 0.9%Should You Sell? - MarketBeat

Nov 08, 2024
pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 29, 2024

Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last? - Yahoo Finance

Oct 29, 2024
pulisher
Oct 18, 2024

Zura Bio (NASDAQ:ZURA) versus Omega Therapeutics (NASDAQ:OMGA) Critical Contrast - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Omega Therapeutics stock hits 52-week low at $0.94 By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Grows Holdings in Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World

Oct 17, 2024
pulisher
Oct 15, 2024

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

Omega Therapeutics to Present Multiple Posters Highlighting - GlobeNewswire

Oct 15, 2024
pulisher
Oct 09, 2024

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - Financial Times

Oct 09, 2024
pulisher
Oct 07, 2024

Omega Therapeutics stock hits 52-week low at $1.07 By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Omega Therapeutics stock hits 52-week low at $1.07 - Investing.com India

Oct 07, 2024
pulisher
Oct 04, 2024

Omega Therapeutics Appoints New Director - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

Omega Therapeutics Welcomes Robert Rosiello to Board - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

Omega Therapeutics Appoints New Director By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 03, 2024

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors – Company Announcement - Financial Times

Oct 03, 2024
pulisher
Oct 02, 2024

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore - Financial Times

Oct 02, 2024
pulisher
Oct 01, 2024

Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Financial Times

Oct 01, 2024
pulisher
Sep 30, 2024

Omega Therapeutics stock hits 52-week low at $1.2 By Investing.com - Investing.com Canada

Sep 30, 2024
pulisher
Sep 30, 2024

Omega Therapeutics stock hits 52-week low at $1.2 - Investing.com

Sep 30, 2024
pulisher
Sep 26, 2024

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry – Company AnnouncementFT.com - Financial Times

Sep 26, 2024
pulisher
Sep 17, 2024

Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications - ForexTV.com

Sep 17, 2024
pulisher
Sep 17, 2024

Omega Therapeutics reports tumor inhibition in liver cancer models - Investing.com

Sep 17, 2024
pulisher
Sep 17, 2024

Omega Therapeutics Announces Publication of Epigenomic - GlobeNewswire

Sep 17, 2024
pulisher
Sep 11, 2024

RNA-Based Therapeutics Market to Grow by USD 1.27 Billion (2024-2028) Due to Increased Investment and Funding, AI Trends Impacting RevenueTechnavio - The Malaysian Reserve

Sep 11, 2024
pulisher
Sep 11, 2024

RNA-Based Therapeutics Market To Grow By USD 1.27 Billion (2024-2028) Due To Increased Investment And Funding, AI Trends Impacting RevenueTechnavio - MENAFN.COM

Sep 11, 2024
pulisher
Sep 10, 2024

Omega Therapeutics (NASDAQ:OMGA) Stock Price Up 0.8% - MarketBeat

Sep 10, 2024
pulisher
Sep 10, 2024

Omega Therapeutics (NASDAQ:OMGA) Shares Up 0.8% - Defense World

Sep 10, 2024
pulisher
Sep 07, 2024

Omega Therapeutics stock hits 52-week low at $1.29 amid downturn - Investing.com Australia

Sep 07, 2024
pulisher
Sep 02, 2024

A look into Omega Therapeutics Inc (OMGA)’s deeper side - SETE News

Sep 02, 2024
pulisher
Aug 30, 2024

Omega Therapeutics inks shared space deals with Flagship affiliates - Investing.com

Aug 30, 2024
pulisher
Aug 30, 2024

Omega Therapeutics inks shared space deals with Flagship affiliates By Investing.com - Investing.com South Africa

Aug 30, 2024
pulisher
Aug 22, 2024

Novo Nordisk to meet Drug Demand with $220M Expansion - European Pharmaceutical Manufacturer

Aug 22, 2024
pulisher
Aug 19, 2024

HC Wainwright Comments on Omega Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:OMGA) - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

HC Wainwright Analysts Boost Earnings Estimates for Omega Therapeutics, Inc. (NASDAQ:OMGA) - Defense World

Aug 19, 2024
pulisher
Aug 15, 2024

Omega Therapeutics' (OMGA) Buy Rating Reiterated at HC Wainwright - MarketBeat

Aug 15, 2024

Omega Therapeutics Inc Stock (OMGA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):